213 related articles for article (PubMed ID: 15586002)
21. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.
Roux PP; Ballif BA; Anjum R; Gygi SP; Blenis J
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13489-94. PubMed ID: 15342917
[TBL] [Abstract][Full Text] [Related]
22. Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
Wang X; Fonseca BD; Tang H; Liu R; Elia A; Clemens MJ; Bommer UA; Proud CG
J Biol Chem; 2008 Nov; 283(45):30482-92. PubMed ID: 18676370
[TBL] [Abstract][Full Text] [Related]
23. Rheb-TOR signaling promotes protein synthesis, but not glucose or amino acid import, in Drosophila.
Hall DJ; Grewal SS; de la Cruz AF; Edgar BA
BMC Biol; 2007 Mar; 5():10. PubMed ID: 17371599
[TBL] [Abstract][Full Text] [Related]
24. Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation.
Uhlmann EJ; Li W; Scheidenhelm DK; Gau CL; Tamanoi F; Gutmann DH
Glia; 2004 Aug; 47(2):180-8. PubMed ID: 15185396
[TBL] [Abstract][Full Text] [Related]
25. Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase.
Avruch J; Hara K; Lin Y; Liu M; Long X; Ortiz-Vega S; Yonezawa K
Oncogene; 2006 Oct; 25(48):6361-72. PubMed ID: 17041622
[TBL] [Abstract][Full Text] [Related]
26. The TSC-mTOR pathway mediates translational activation of TOP mRNAs by insulin largely in a raptor- or rictor-independent manner.
Patursky-Polischuk I; Stolovich-Rain M; Hausner-Hanochi M; Kasir J; Cybulski N; Avruch J; Rüegg MA; Hall MN; Meyuhas O
Mol Cell Biol; 2009 Feb; 29(3):640-9. PubMed ID: 19047368
[TBL] [Abstract][Full Text] [Related]
27. Farnesyltransferase inhibitors reverse altered growth and distribution of actin filaments in Tsc-deficient cells via inhibition of both rapamycin-sensitive and -insensitive pathways.
Gau CL; Kato-Stankiewicz J; Jiang C; Miyamoto S; Guo L; Tamanoi F
Mol Cancer Ther; 2005 Jun; 4(6):918-26. PubMed ID: 15956249
[TBL] [Abstract][Full Text] [Related]
28. Distinct effects of single amino-acid changes to tuberin on the function of the tuberin-hamartin complex.
Nellist M; Sancak O; Goedbloed MA; Rohe C; van Netten D; Mayer K; Tucker-Williams A; van den Ouweland AM; Halley DJ
Eur J Hum Genet; 2005 Jan; 13(1):59-68. PubMed ID: 15483652
[TBL] [Abstract][Full Text] [Related]
29. TSC1/TSC2 and Rheb have different effects on TORC1 and TORC2 activity.
Yang Q; Inoki K; Kim E; Guan KL
Proc Natl Acad Sci U S A; 2006 May; 103(18):6811-6. PubMed ID: 16627617
[TBL] [Abstract][Full Text] [Related]
30. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies.
Shah OJ; Wang Z; Hunter T
Curr Biol; 2004 Sep; 14(18):1650-6. PubMed ID: 15380067
[TBL] [Abstract][Full Text] [Related]
31. Rheb promotes cell growth as a component of the insulin/TOR signalling network.
Saucedo LJ; Gao X; Chiarelli DA; Li L; Pan D; Edgar BA
Nat Cell Biol; 2003 Jun; 5(6):566-71. PubMed ID: 12766776
[TBL] [Abstract][Full Text] [Related]
32. Tumour suppressors hamartin and tuberin: intracellular signalling.
Krymskaya VP
Cell Signal; 2003 Aug; 15(8):729-39. PubMed ID: 12781866
[TBL] [Abstract][Full Text] [Related]
33. Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1.
Wang H; Kubica N; Ellisen LW; Jefferson LS; Kimball SR
J Biol Chem; 2006 Dec; 281(51):39128-34. PubMed ID: 17074751
[TBL] [Abstract][Full Text] [Related]
34. Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency.
Long X; Ortiz-Vega S; Lin Y; Avruch J
J Biol Chem; 2005 Jun; 280(25):23433-6. PubMed ID: 15878852
[TBL] [Abstract][Full Text] [Related]
35. Tuberous sclerosis: from tubers to mTOR.
Kwiatkowski DJ
Ann Hum Genet; 2003 Jan; 67(Pt 1):87-96. PubMed ID: 12556239
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of tuberin as a novel mechanism for somatic inactivation of the tuberous sclerosis complex proteins in brain lesions.
Han S; Santos TM; Puga A; Roy J; Thiele EA; McCollin M; Stemmer-Rachamimov A; Ramesh V
Cancer Res; 2004 Feb; 64(3):812-6. PubMed ID: 14871804
[TBL] [Abstract][Full Text] [Related]
37. Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis.
Shah OJ; Hunter T
Mol Cell Biol; 2006 Sep; 26(17):6425-34. PubMed ID: 16914728
[TBL] [Abstract][Full Text] [Related]
38. Identification of mechanically regulated phosphorylation sites on tuberin (TSC2) that control mechanistic target of rapamycin (mTOR) signaling.
Jacobs BL; McNally RM; Kim KJ; Blanco R; Privett RE; You JS; Hornberger TA
J Biol Chem; 2017 Apr; 292(17):6987-6997. PubMed ID: 28289099
[TBL] [Abstract][Full Text] [Related]
39. To cease or to proliferate: new insights into TCTP function from a Drosophila study.
Choi KW; Hsu YC
Cell Adh Migr; 2007; 1(3):129-30. PubMed ID: 19262129
[TBL] [Abstract][Full Text] [Related]
40. The mTOR/S6K signalling pathway: the role of the TSC1/2 tumour suppressor complex and the proto-oncogene Rheb.
Nobukini T; Thomas G
Novartis Found Symp; 2004; 262():148-54; discussion 154-9, 265-8. PubMed ID: 15562827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]